Concepedia

Ruben C. Hartkoorn

RC

51

Publications

3.9K

Citations

33

H-Index

2005

Active since

Affiliations

École Polytechnique Fédérale de Lausanne(Current)

Inserm

Institut Pasteur de Lille

Centre National de la Recherche Scientifique

Center for Infection and Immunity of Lille

Ruben C. Hartkoorn is an author at École Polytechnique Fédérale de Lausanne specializing in medicine, pharmacology, and drug resistance.

ORCID

Top concepts

Publications per year

2005–2023

51

Publications

51

Cross-Resistance between Clofazimine and Bedaquiline through Upregulation of MmpL5 in Mycobacterium tuberculosis

Ruben C. Hartkoorn, Swapna Uplekar, Stewart T. Cole · Antimicrobial Agents and Chemotherapy · 2014 · 476 citations · Full text

, , +16

Towards a new combination therapy for tuberculosis with next generation benzothiazinones

Vadim Makarov, Benoît Lechartier, Ming Zhang et al. · EMBO Molecular Medicine · 2014 · 379 citations · Full text

, , +10

Towards a new tuberculosis drug: pyridomycin – nature's isoniazid

Ruben C. Hartkoorn, Claudia Sala, João Neres et al. · EMBO Molecular Medicine · 2012 · 184 citations · Full text

HIV protease inhibitors are substrates for OATP1A2, OATP1B1 and OATP1B3 and lopinavir plasma concentrations are influenced by SLCO1B1 polymorphisms

Ruben C. Hartkoorn, Wai San Kwan, Victoria Shallcross et al. · Pharmacogenetics and Genomics · 2010 · 174 citations · Full text

Virulence Regulator EspR of Mycobacterium tuberculosis Is a Nucleoid-Associated Protein

Benjamin Blasco, Jeffrey M. Chen, Ruben C. Hartkoorn et al. · PLoS Pathogens · 2012 · 138 citations · Full text

, , +21

Rows per page

1–5 of 51